Literature DB >> 18311077

A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.

Martin R Farlow1, Jeffrey Cummings.   

Abstract

BACKGROUND/AIMS: Parkinson's disease dementia (PDD) is common, but its neuropathological basis has been controversial. The aim of this review was to survey the recent literature on the pathology of PDD and compare the pathology of PDD to that of Alzheimer's disease (AD).
METHODS: A literature search was performed to identify relevant research published since 2001.
RESULTS: There is widespread Lewy body pathology in the neocortex and subcortical regions in PDD, and Lewy neurites in the CA2 region of the hippocampus that correlate with cognitive decline. Genetic forms of PD, which frequently lead to dementia, are associated with deposition of alpha-synuclein; PDD is not related to the apolipoprotein E epsilon 4 genotype. Compared with AD, central cholinergic deficits occur earlier, are greater and more widespread in PDD, but PDD can occur without the abundant senile plaques and neurofibrillary tangles indicative of AD.
CONCLUSION: Epidemiological investigations, neuroimaging, as well as genetic and neuropathological studies increasingly support PDD as distinct from AD. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18311077     DOI: 10.1159/000119104

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  9 in total

1.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

2.  Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.

Authors:  Frederick A Schmitt; Martin R Farlow; Xiangyi Meng; Sibel Tekin; Jason T Olin
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

Review 3.  Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2012-02-18       Impact factor: 3.575

4.  Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.

Authors:  Nobuto Shibata; Yumiko Motoi; Hiroyuki Tomiyama; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Miwa Komatsu; Hiromi Shimazaki; Nobutaka Hattori; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-05-18

5.  Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia.

Authors:  Martin R Farlow; Frederick Schmitt; Dag Aarsland; George T Grossberg; Monique Somogyi; Xiangyi Meng
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-09-11

Review 6.  Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia.

Authors:  Sun-Ah Choi; Virgilio Gerald H Evidente; John N Caviness
Journal:  J Mov Disord       Date:  2010-04-30

7.  Neuroimaging in Parkinson's disease dementia: connecting the dots.

Authors:  Rimona S Weil; Joey K Hsu; Ryan R Darby; Louis Soussand; Michael D Fox
Journal:  Brain Commun       Date:  2019-07-08

Review 8.  Diagnosis and management of Parkinson's disease dementia.

Authors:  W Poewe; S Gauthier; D Aarsland; J B Leverenz; P Barone; D Weintraub; E Tolosa; B Dubois
Journal:  Int J Clin Pract       Date:  2008-10       Impact factor: 2.503

9.  Houttuynia cordata Improves Cognitive Deficits in Cholinergic Dysfunction Alzheimer's Disease-Like Models.

Authors:  Eugene Huh; Hyo Geun Kim; Hanbyeol Park; Min Seo Kang; Bongyong Lee; Myung Sook Oh
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.